DOCSLIB.ORG

Computational Methods to Identify and Target Druggable Binding Sites at Protein-Protein Interactions in the Human Proteome

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Computational Methods to Identify and Target Druggable Binding Sites at Protein-Protein Interactions in the Human Proteome COMPUTATIONAL METHODS TO IDENTIFY AND TARGET DRUGGABLE BINDING SITES AT PROTEIN-PROTEIN INTERACTIONS IN THE HUMAN PROTEOME David Xu Submitted to the faculty of the University Graduate School in partial fulfillment of the requirements for the degree Doctor of Philosophy in the School of Informatics and Computing, Indiana University September 2019 Accepted by the Graduate Faculty of Indiana University, in partial fulfillment of the requirements for the degree of Doctor of Philosophy. Doctoral Committee ______________________________________ Huanmei Wu, PhD, Co-Chair ______________________________________ Samy Meroueh, PhD, Co-Chair April 15, 2019 ______________________________________ Xiaowen Liu, PhD ______________________________________ Sarath Chandra Janga, PhD ______________________________________ Yunlong Liu, PhD ii © 2019 David Xu iii DEDICATION To my family, without whom this journey would not be possible. iv ACKNOWLEDGEMENT First and foremost, I would like to express my sincere appreciation to my advisor Dr. Samy Meroueh for his support during my graduate studies and related research over the past years. I would also like to thank him for his insight, generosity, and support throughout this experience, without whom this would not be possible. Sincere gratitude is given to my committee co-chair, Dr. Huanmei Wu, for her time and guidance through the Ph.D. process. I would also like to thank all my committee members, Dr. Xiaowen Liu, Dr. Sarath Chandra Janga, and Dr. Yunlong Liu, for their valuable comments and suggestions on my work. I would like to express my sincerest gratitude to all my colleagues through the years in the Center for Computational Biology and Bioinformatics: Dr. Liwei Li, Dr. Yubing Si, Dr. Michael Wu, Dr. Jack Chiang, Dr. Hai Lin, Bo Wang, and many others, for thoughtful discussions and valuable insights into the interdisciplinary field of bioinformatics. I would also like to thank the other members of the lab, Dr. Khuchtumur Bum-Erdene, Dr. Donghui Zhou, Dr. Degang Liu, and Mona Ghozayel, without whom much of this work would remain computational and without validation. I am grateful to collaborators at the Open Science Grid, including Rob Quick, Scott Teige, and Mats Rynge, for providing high-throughput computational resources without which much of this work would not be possible. I am indebted to Dr. Yaoqi Zhou, who guided me through the first year of my MS study. I am thankful to my undergraduate research advisor, Dr. John Cheeseman, who introduced me to the research process. Finally, I would like to express my deepest love to my family. My dearest thanks to my late father, Dr. Jigeng Xu, who passed away unexpected during my Ph.D. journey, but has forever instilled the drive for hard work and focus that made this work possible. To my mother, Li Lu, who taught me to be honest and warm, who I know will forever support me in my journey wherever it may go. To my little sister, Alice, for her love and support over the years. v David Xu COMPUTATIONAL METHODS TO IDENTIFY AND TARGET DRUGGABLE BINDING SITES AT PROTEIN-PROTEIN INTERACTIONS IN THE HUMAN PROTEOME Protein-protein interactions are fundamental in cell signaling and cancer progression. An increasing prevalent idea in cancer therapy is the development of small molecules to disrupt protein-protein interactions. Small molecules impart their action by binding to pockets on the protein surface of their physiological target. At protein-protein interactions, these pockets are often too large and tight to be disrupted by conventional design techniques. Residues that contribute a disproportionate amount of energy at these interfaces are known as hot spots. The successful disruption of protein-protein interactions with small molecules is attributed to the ability of small molecules to mimic and engage these hot spots. Here, the role of hot spots is explored in existing inhibitors and compared with the native protein ligand to explore how hot spot residues can be leveraged in protein-protein interactions. Few studies have explored the use of interface residues for the identification of hit compounds from structure-based virtual screening. The tight uPAR•uPA interaction offers a platform to test methods that leverage hot spots on both the protein receptor and ligand. A method is described that enriches for small molecules that both engage hot spots on the protein receptor uPAR and mimic hot spots on its protein ligand uPA. In addition, differences in chemical diversity in mimicking ligand hot spots is explored. In addition to uPAR•uPA, there are additional opportunities at unperturbed protein-protein interactions implicated in cancer. Projects such as TCGA, which systematically catalog the hallmarks of cancer across multiple platforms, provide opportunities to identify novel protein- protein interactions that are paramount to cancer progression. To that end, a census of cancer- specific binding sites in the human proteome are identified to provide opportunities for drug discovery at the system level. Finally, tumor genomic, protein-protein interaction, and protein structural data is integrated to create chemogenomic libraries for phenotypic screening to uncover novel GBM targets and generate starting points for the development of GBM therapeutic agents. Huanmei Wu, PhD, Co-Chair Samy Meroueh, PhD, Co-Chair vi TABLE OF CONTENTS List of Tables ................................................................................................................................. xii List of Figures ............................................................................................................................... xiii Chapter 1. Introduction .................................................................................................................... 1 1.1 Background ......................................................................................................................... 1 1.1.1 Cancer Genomics ....................................................................................................... 1 1.1.2 Protein-Protein Interactions ....................................................................................... 1 1.2 Challenges Addressed ......................................................................................................... 3 1.3 Major Contributions ............................................................................................................ 4 Chapter 2. A Computational Investigation of Small-Molecule Engagement of Hot Spots at Protein-Protein Interaction Interfaces ............................................................................................ 11 2.1 Introduction ....................................................................................................................... 11 2.2 Results ............................................................................................................................... 12 2.2.1 Protein-Protein and Protein-Compound Complexes ................................................ 12 2.2.2 Molecular Dynamics Simulations and Free Energy Calculations ............................ 18 2.2.3 Computational Alanine Scanning and Free Energy Decomposition ........................ 22 2.2.4 Bcl-xL•Bak .............................................................................................................. 22 2.2.5 MDM2•p53 .............................................................................................................. 27 2.2.6 XIAP•Smac .............................................................................................................. 30 2.2.7 IL-2•IL-2Rα ............................................................................................................. 34 2.2.8 BRD4•H4 ................................................................................................................. 38 2.2.9 Mimicking Hot Spots on the Protein Ligand ........................................................... 41 2.2.10 Effect of Native Protein Ligand and Small-Molecule Inhibitors on Receptor Dynamics ........................................................................................................... 49 2.3 Discussion ......................................................................................................................... 49 2.4 Materials and Methods ...................................................................................................... 51 2.4.1 Structural Preparation .............................................................................................. 51 2.4.2 Molecular Dynamics ................................................................................................ 52 2.4.3 Free Energy Calculations ......................................................................................... 53 2.4.4 Alanine Scanning ..................................................................................................... 54 2.4.5 Decomposition Energy............................................................................................. 54 2.4.6 Ligand Pharmacophore ............................................................................................ 56 2.4.7 Dynamic Cross-Correlation Matrix ......................................................................... 56 2.4.8 Statistical Analysis ................................................................................................... 57 vii Chapter 3. Mimicking Intermolecular Interactions of Tight Protein-Protein
Load more

Recommended publications
  • Screening and Identification of Key Biomarkers in Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Screening and identification of key biomarkers in clear cell renal cell carcinoma based on bioinformatics analysis Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Clear cell renal cell carcinoma (ccRCC) is one of the most common types of malignancy of the urinary system. The pathogenesis and effective diagnosis of ccRCC have become popular topics for research in the previous decade. In the current study, an integrated bioinformatics analysis was performed to identify core genes associated in ccRCC. An expression dataset (GSE105261) was downloaded from the Gene Expression Omnibus database, and included 26 ccRCC and 9 normal kideny samples. Assessment of the microarray dataset led to the recognition of differentially expressed genes (DEGs), which was subsequently used for pathway and gene ontology (GO) enrichment analysis.
    [Show full text]
  • Cyclotides Evolve
    Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 218 Cyclotides evolve Studies on their natural distribution, structural diversity, and activity SUNGKYU PARK ACTA UNIVERSITATIS UPSALIENSIS ISSN 1651-6192 ISBN 978-91-554-9604-3 UPPSALA urn:nbn:se:uu:diva-292668 2016 Dissertation presented at Uppsala University to be publicly examined in B/C4:301, BMC, Husargatan 3, Uppsala, Friday, 10 June 2016 at 09:00 for the degree of Doctor of Philosophy (Faculty of Pharmacy). The examination will be conducted in English. Faculty examiner: Professor Mohamed Marahiel (Philipps-Universität Marburg). Abstract Park, S. 2016. Cyclotides evolve. Studies on their natural distribution, structural diversity, and activity. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 218. 71 pp. Uppsala: Acta Universitatis Upsaliensis. ISBN 978-91-554-9604-3. The cyclotides are a family of naturally occurring peptides characterized by cyclic cystine knot (CCK) structural motif, which comprises a cyclic head-to-tail backbone featuring six conserved cysteine residues that form three disulfide bonds. This unique structural motif makes cyclotides exceptionally resistant to chemical, thermal and enzymatic degradation. They also exhibit a wide range of biological activities including insecticidal, cytotoxic, anti-HIV and antimicrobial effects. The cyclotides found in plants exhibit considerable sequence and structural diversity, which can be linked to their evolutionary history and that of their host plants. To clarify the evolutionary link between sequence diversity and the distribution of individual cyclotides across the genus Viola, selected known cyclotides were classified using signature sequences within their precursor proteins. By mapping the classified sequences onto the phylogenetic system of Viola, we traced the flow of cyclotide genes over evolutionary history and were able to estimate the prevalence of cyclotides in this genus.
    [Show full text]
  • Overexpresssion of Tyrosine Kinase Discoidin Domain Receptor I (DDR1 ) in Transitional Cell Carcinoma
    Overexpresssion of Tyrosine Kinase Discoidin domain receptor I (DDR1 ) in Transitional cell Carcinoma Szu-Ting Chen,* and Shie-Liang Hsieh* Institute and Department of Microbiology and Immunology, National Yang-Ming University, Taipei, Taiwan; To whom proofs are to be sent: Shie-Liang Hsieh, Department and Institute of Microbiology and Immunology, National Yang-Ming University, Shih-Pai, Taipei 112, Taiwan. E-mail address: [email protected] Telephone number: 886-2-28267161 Fax number: 886-2-28277933 INTRODUCTION DDR1, discoidin domain receptor 1, belongs to the novel subfamily of tyrosine kinase receptor, which forms homodimer upon ligand engagement. DDR1 is distinguished from other receptor tyrosine kinase by the discoidin domain in their extracellular domain, which is a homology region originally identified in Dictyostelium discoideum (slime mold) protein, discoidin I, and involves in cells aggregation. Discoidin-1 has binding specificity toward galactose and N-acetyl galactosamine and is essential for slime mold cells adhesion, migration and aggregation during its development, suggesting that DDR1 shared similar biologically function in mammalian [1-3]. DDR1 has been found mainly distributed and in human tissue epithelia, such as kidney, breast, lung [3], bronchial [4] and keratinocytes [5]. Furthermore, DDR1 has been also reported its expression in immune system like the monocyte-derived dendritic cells, annotated as CD167 [6] and macrophage[7]. However, recently, the overexpression of DDR1 has been detected in several human cancers, such as primary breast cancer [1, 8, 9] ovarian[10, 11], brain[12], esophageal cancer [13], and TCC (our data unpublished) in which raising the possibility that DDR1 may play a important role in tumorigenesis [14].
    [Show full text]
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • Of Modified Peptides 660 Absorption
    Index A Aequorea victoria 182, 192 post-column aerosols, danger of contamination 770 derivatization 303–305 Abbe, Ernst 181, 187, 485, 493 affinity capillary electrophoresis pre-column absolute molecule mass 4 (ACE) 285–286 derivatization 305–308 absolute quantification (AQUA) of binding constant, determined by 285 reagents used for 310 modified peptides 660 changing mobility 286 sample preparation 302 absorption complexation of monovalent acidic hydrolysis 302 bands, of most biological molecules 139 protein–ligand complexes 285 alkaline hydrolysis 303 measurement 140–142 affinity chromatography 91, 268, 650 enzymatic hydrolysis 303 of photon 135 affinity purification mass spectrometry using mass spectrometry 309 spectroscopy 131 (AP-MS) 381, 1003 L-α-amino acid residues/termini 225 acetic acid 228 agarose concentrations amino acid sequence analysis acetonitrile 227 DNA fragments, coarse separation milestones in 319 N-acetyl-α-D-glucosamine of 692 problems 322 (αGlcNAc) 579 migration distance and fragment amino acids 323–324 acetylated proteins length 692 background 324 detection of 651 agarose gels, advantages of 260 initial yield 324 separation and enrichment 649 agglutination 72 modified amino acids 324 acetylation 224, 645–647 aggregation number 288 purity of chemicals 324 sites, in proteins 656 AK2-antibodies 102 sample to be sequenced 322–323 identification of 655 alanine 562 sensitivity of HPLC system 325 N-acetyl-β-D-glucosamine alanine-scanning method 870 state of the art 325 (βGlcNAc) 579 albumin 3, 995 6-aminoquinoyl-N-hydroxysuccinimidyl
    [Show full text]
  • High-Throughput Mutagenesis Reveals Functional Determinants for DNA Targeting by Activation-Induced Deaminase Kiran S
    9964–9975 Nucleic Acids Research, 2014, Vol. 42, No. 15 Published online 26 July 2014 doi: 10.1093/nar/gku689 High-throughput mutagenesis reveals functional determinants for DNA targeting by activation-induced deaminase Kiran S. Gajula1, Peter J. Huwe2,†, Charlie Y. Mo3,†, Daniel J. Crawford1, James T. Stivers4, Ravi Radhakrishnan2 and Rahul M. Kohli1,3,* 1Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA, 2Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA, 3Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA and 4Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA Received June 7, 2014; Revised July 16, 2014; Accepted July 16, 2014 ABSTRACT tional scanning and may find general utility for high- throughput analysis of protein function. Antibody maturation is a critical immune process governed by the enzyme activation-induced deam- inase (AID), a member of the AID/APOBEC DNA INTRODUCTION deaminase family. AID/APOBEC deaminases prefer- Enzyme families often share a central well-structured cat- entially target cytosine within distinct preferred se- alytic core, with different specificities among family mem- quence motifs in DNA, with specificity largely con- bers encoded by variable regions surrounding the active ferred by a small 9–11 residue protein loop that dif- site core (1,2). This mechanism for fulfilling the need for fers among family members. Here, we aimed to deter- specialization while maintaining core function is evident in / mine the key functional characteristics of this protein the family of AID APOBEC cytosine deaminase enzymes, loop in AID and to thereby inform our understanding which play an important role in adaptive and innate immu- nity.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Anti- Histone-H3 Antibody
    anti- Histone-H3 antibody Product Information Catalog No.: FNab03890 Size: 100μg Form: liquid Purification: Immunogen affinity purified Purity: ≥95% as determined by SDS-PAGE Host: Rabbit Clonality: polyclonal Clone ID: None IsoType: IgG Storage: PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months (Avoid repeated freeze / thaw cycles.) Background HIST2H3A,histone cluster 2, H3a.It is the core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. HIST2H3A is Expressed during S phase, then expression strongly decreases as cell division slows down during the process of differentiation. Immunogen information Immunogen: histone cluster 2, H3a Synonyms: H3/n, H3/o, H3F2, H3FM, HIST2H3A, HIST2H3C, HIST2H3D, histone cluster 2, H3a, Histone H3, Histone H3.2, Histone H3/m, Histone H3/o Observed MW: 15-17 kDa Uniprot ID : Q71DI3 Application 1 Wuhan Fine Biotech Co., Ltd. B9 Bld, High-Tech Medical Devices Park, No. 818 Gaoxin Ave.East Lake High-Tech Development Zone.Wuhan, Hubei, China(430206) Tel :( 0086)027-87384275 Fax: (0086)027-87800889 www.fn-test.com Reactivity: Human, Mouse, Rat Tested Application: ELISA, WB, IHC, IF Recommended dilution: WB: 1:500-1:5000; IHC: 1:50-1:200; IF: 1:20-1:200 Image: Immunohistochemistry of paraffin-embedded human breast cancer tissue slide using FNab03890(Histone-H3 Antibody) at dilution of 1:50 Immunofluorescent analysis of HEK-293 cells using FNab03890 (Histone-H3 Antibody) at dilution of 1:50 and Rhodamine-Goat anti-Rabbit IgG 2 Wuhan Fine Biotech Co., Ltd.
    [Show full text]
  • Tumor Necrosis Factor‑Α‑Induced Protein‑8 Like 2 Regulates
    6346 MOLECULAR MEDICINE REPORTS 16: 6346-6353, 2017 Tumor necrosis factor‑α‑induced protein‑8 like 2 regulates lipopolysaccharide‑induced rat rheumatoid arthritis immune responses and is associated with Rac activation and interferon regulatory factor 3 phosphorylation CHUNYAN SHI1,2*, YUE WANG1*, GUOHONG ZHUANG1*, ZHONGQUAN QI1, YANPING LI1 and PING YIN3 1Organ Transplantation Institute, Anti‑Cancer Research Center, Medical College, Xiamen University, Xiamen, Fujian 361100; 2The Department of Oncology, Jiujiang People's Hospital, Jiujiang, Jiangxi 332000; 3Department of Pathology, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, Fujian 361100, P.R. China Received October 28, 2016; Accepted June 19, 2017 DOI: 10.3892/mmr.2017.7311 Abstract. The endogenously activated rheumatoid arthritis Introduction (R A) synovial fibroblasts (RSFs) a re li kely to be the key to cur ing the disease. RSFs express Toll‑like receptors (TLRs) rendering Rheumatoid arthritis (RA) is a chronic inflammatory disease them prone to activation by exogenous and endogenous TLR characterized by articular inflammation and leads to joint ligands, resulting in the production of chemokines and cyto- destruction (1,2). RA pathogenesis involves a complex kines Germline deletion of tumor necrosis factor‑α-induced humoral and cellular immune response, including the infiltra- protein‑8 like 2 (TIPE2, also known as TNFAIP8L2) results tion of lymphocytes and monocytes into the synovium. These in fatal inflammation and hypersensitivity to TLR and T cell infiltrating cells and synoviocytes release numerous proin- receptor stimulation. The present study demonstrates an flammatory cytokine and chemokines, including interleukin inverse association between TIPE2 and cytokine gene expres- IL‑6, IL‑1 and tumor necrosis factor‑α (TNF‑α), which may sion in RSFs following lipopolysaccharide (LPS) stimulation.
    [Show full text]
  • Inhibition of DDR1-BCR Signalling by Nilotinib As a New Therapeutic
    Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer Maya Jeitany, Cédric Leroy, Priscillia Tosti, Marie Lafitte, Jordy Le Guet, Valérie Simon, Debora Bonenfant, Bruno Robert, Fanny Grillet, Caroline Mollevi, et al. To cite this version: Maya Jeitany, Cédric Leroy, Priscillia Tosti, Marie Lafitte, Jordy Le Guet, et al.. Inhibition of DDR1- BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer. EMBO Molecular Medicine, Wiley Open Access, 2018, 10 (4), pp.e7918. 10.15252/emmm.201707918. hal- 01872978 HAL Id: hal-01872978 https://hal.archives-ouvertes.fr/hal-01872978 Submitted on 12 Jan 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License Research Article Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer Maya Jeitany1,†, Cédric Leroy1,2,3,†, Priscillia Tosti1,†, Marie Lafitte1, Jordy Le Guet1, Valérie Simon1, Debora Bonenfant2, Bruno Robert4, Fanny Grillet5, Caroline Mollevi4, Safia El Messaoudi4, Amaëlle Otandault4, Lucile Canterel-Thouennon4, Muriel Busson4, Alain R Thierry4, Pierre Martineau4, Julie Pannequin5, Serge Roche1,*,† & Audrey Sirvent1,†,** Abstract The current clinical management involves surgical removal of the primary tumour, often associated with chemotherapy.
    [Show full text]
  • Genetic and Pharmacological Approaches to Preventing Neurodegeneration
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2012 Genetic and Pharmacological Approaches to Preventing Neurodegeneration Marco Boccitto University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Neuroscience and Neurobiology Commons Recommended Citation Boccitto, Marco, "Genetic and Pharmacological Approaches to Preventing Neurodegeneration" (2012). Publicly Accessible Penn Dissertations. 494. https://repository.upenn.edu/edissertations/494 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/494 For more information, please contact [email protected]. Genetic and Pharmacological Approaches to Preventing Neurodegeneration Abstract The Insulin/Insulin-like Growth Factor 1 Signaling (IIS) pathway was first identified as a major modifier of aging in C.elegans. It has since become clear that the ability of this pathway to modify aging is phylogenetically conserved. Aging is a major risk factor for a variety of neurodegenerative diseases including the motor neuron disease, Amyotrophic Lateral Sclerosis (ALS). This raises the possibility that the IIS pathway might have therapeutic potential to modify the disease progression of ALS. In a C. elegans model of ALS we found that decreased IIS had a beneficial effect on ALS pathology in this model. This beneficial effect was dependent on activation of the transcription factor daf-16. To further validate IIS as a potential therapeutic target for treatment of ALS, manipulations of IIS in mammalian cells were investigated for neuroprotective activity. Genetic manipulations that increase the activity of the mammalian ortholog of daf-16, FOXO3, were found to be neuroprotective in a series of in vitro models of ALS toxicity.
    [Show full text]
  • Protein Interactions in the Cancer Proteome† Cite This: Mol
    Molecular BioSystems View Article Online PAPER View Journal | View Issue Small-molecule binding sites to explore protein– protein interactions in the cancer proteome† Cite this: Mol. BioSyst., 2016, 12,3067 David Xu,ab Shadia I. Jalal,c George W. Sledge Jr.d and Samy O. Meroueh*aef The Cancer Genome Atlas (TCGA) offers an unprecedented opportunity to identify small-molecule binding sites on proteins with overexpressed mRNA levels that correlate with poor survival. Here, we analyze RNA-seq and clinical data for 10 tumor types to identify genes that are both overexpressed and correlate with patient survival. Protein products of these genes were scanned for binding sites that possess shape and physicochemical properties that can accommodate small-molecule probes or therapeutic agents (druggable). These binding sites were classified as enzyme active sites (ENZ), protein–protein interaction sites (PPI), or other sites whose function is unknown (OTH). Interestingly, the overwhelming majority of binding sites were classified as OTH. We find that ENZ, PPI, and OTH binding sites often occurred on the same structure suggesting that many of these OTH cavities can be used for allosteric modulation of Creative Commons Attribution 3.0 Unported Licence. enzyme activity or protein–protein interactions with small molecules. We discovered several ENZ (PYCR1, QPRT,andHSPA6)andPPI(CASC5, ZBTB32,andCSAD) binding sites on proteins that have been seldom explored in cancer. We also found proteins that have been extensively studied in cancer that have not been previously explored with small molecules that harbor ENZ (PKMYT1, STEAP3,andNNMT) and PPI (HNF4A, MEF2B,andCBX2) binding sites. All binding sites were classified by the signaling pathways to Received 29th March 2016, which the protein that harbors them belongs using KEGG.
    [Show full text]